To investigate whether these results were clinically relevant, five matched glioma tissues were collected from the initial surgical treatment for untreated tumors and from the second surgical treatment after radiation and TMZ chemotherapy treatment failure for ZDHHC17 and MAP2K4 IHC analysis. This evidence concerns the gene MAP2K4 and central nervous system cancer.